BACKGROUND: African non-human primates are SIV natural hosts and do not develop disease following infection. Understanding disease avoidance mechanisms in these species is important for HIV vaccine development. The largest captive population of sooty mangabeys, a SIV natural host species, resides at the Yerkes National Primate Research Center. METHODS: Thirteen primer sets that amplify polymorphic microsatellite loci within the MHC region were used to genotype 144 animals. Immunogenetic Management Software (IMS) was used to identify MHC haplotypes and organize data. RESULTS: Seventy-three haplotypes were identified. Limited haplotype diversity was observed in this population with 88.2% of included animals carrying one of 18 haplotypes. Differences in haplotype frequency were observed between SIV (+) and SIV (-) populations. CONCLUSIONS: We have developed a novel tool for others to use in the analysis of the role of the MHC in a natural host non-human primate model species used for SIV research.
BACKGROUND:African non-human primates are SIV natural hosts and do not develop disease following infection. Understanding disease avoidance mechanisms in these species is important for HIV vaccine development. The largest captive population of sooty mangabeys, a SIV natural host species, resides at the Yerkes National Primate Research Center. METHODS: Thirteen primer sets that amplify polymorphic microsatellite loci within the MHC region were used to genotype 144 animals. Immunogenetic Management Software (IMS) was used to identify MHC haplotypes and organize data. RESULTS: Seventy-three haplotypes were identified. Limited haplotype diversity was observed in this population with 88.2% of included animals carrying one of 18 haplotypes. Differences in haplotype frequency were observed between SIV (+) and SIV (-) populations. CONCLUSIONS: We have developed a novel tool for others to use in the analysis of the role of the MHC in a natural host non-human primate model species used for SIV research.
Authors: Shelby L O'Connor; Alex J Blasky; Chad J Pendley; Ericka A Becker; Roger W Wiseman; Julie A Karl; Austin L Hughes; David H O'Connor Journal: Immunogenetics Date: 2007-03-24 Impact factor: 2.846
Authors: M Cecilia T Penedo; Ronald E Bontrop; Corrine M C Heijmans; Nel Otting; Riet Noort; Annemiek J M Rouweler; Nanine de Groot; Natasja G de Groot; Thea Ward; Gaby G M Doxiadis Journal: Immunogenetics Date: 2005-04-05 Impact factor: 2.846
Authors: Donald L Sodora; Jonathan S Allan; Cristian Apetrei; Jason M Brenchley; Daniel C Douek; James G Else; Jacob D Estes; Beatrice H Hahn; Vanessa M Hirsch; Amitinder Kaur; Frank Kirchhoff; Michaela Muller-Trutwin; Ivona Pandrea; Jörn E Schmitz; Guido Silvestri Journal: Nat Med Date: 2009-08 Impact factor: 53.440
Authors: P A Marx; Y Li; N W Lerche; S Sutjipto; A Gettie; J A Yee; B H Brotman; A M Prince; A Hanson; R G Webster Journal: J Virol Date: 1991-08 Impact factor: 5.103
Authors: Gaby G M Doxiadis; Corrine M C Heijmans; Maxime Bonhomme; Nel Otting; Brigitte Crouau-Roy; Ronald E Bontrop Journal: PLoS One Date: 2009-01-27 Impact factor: 3.240
Authors: Emily Adland; Jonathan M Carlson; Paolo Paioni; Henrik Kløverpris; Roger Shapiro; Anthony Ogwu; Lynn Riddell; Graz Luzzi; Fabian Chen; Thambiah Balachandran; David Heckerman; Anette Stryhn; Anne Edwards; Thumbi Ndung'u; Bruce D Walker; Søren Buus; Philip Goulder; Philippa C Matthews Journal: PLoS One Date: 2013-09-02 Impact factor: 3.240
Authors: Katelyn E Heimbruch; Julie A Karl; Roger W Wiseman; Dawn M Dudley; Zach Johnson; Amitinder Kaur; David H O'Connor Journal: Immunogenetics Date: 2015-05-26 Impact factor: 2.846